The Role of the Bacteroides spp. in Bacteraemia

1 Alauzet C., Lozniewski A., Marchandin H.: Metronidazole resistance and nim genes in anaerobes: A review. Anaerobe, 55, 40–53 (2019) AlauzetC. LozniewskiA. MarchandinH. Metronidazole resistance and nim genes in anaerobes: A review Anaerobe 55 40 53 2019 10.1016/j.anaerobe.2018.10.00430316817 Search in Google Scholar

2 Ank N., Sydenham T.V., Iversen L.H., Justesen U.S., Wang M.: Characterisation of a multidrug-resistant Bacteroides fragilis isolate recovered from blood of a patient in Denmark using whole-genome sequencing. Int. J. Antimicrob. Agents, 46, 117–120 (2015) AnkN. SydenhamT.V. IversenL.H. JustesenU.S. WangM. Characterisation of a multidrug-resistant Bacteroides fragilis isolate recovered from blood of a patient in Denmark using whole-genome sequencing Int. J. Antimicrob. Agents 46 117 120 2015 10.1016/j.ijantimicag.2015.02.02425940770 Search in Google Scholar

3 Baaity Z., Jamal W., Rotimi V.O., Burián K., Leitsch D., Somogyvári F., Nagy E., Sóki J. Molecular characterization of metronidazole resistant Bacteroides strains from Kuwait. Anaerobe, doi: 10.1016/j.anaerobe.2021.102357 (2021) BaaityZ. JamalW. RotimiV.O. BuriánK. LeitschD. SomogyváriF. NagyE. SókiJ. Molecular characterization of metronidazole resistant Bacteroides strains from Kuwait Anaerobe 10.1016/j.anaerobe.2021.102357 2021 33713801 Open DOISearch in Google Scholar

4 Brook I.: Bacteraemia due to anaerobic bacteria in newborns. J. Perinatol. 10, 351–356 (1991) BrookI. Bacteraemia due to anaerobic bacteria in newborns J. Perinatol. 10 351 356 1991 Search in Google Scholar

5 Brook I.: The role of anaerobic bacteria in bacteraemia. Anaerobe, 16, 183–189 (2010) BrookI. The role of anaerobic bacteria in bacteraemia Anaerobe 16 183 189 2010 10.1016/j.anaerobe.2009.12.00120025984 Search in Google Scholar

6 Brook I.: Spectrum and treatment of anaerobic infections. J. Infect. Chemother. 22, 1–13 (2016) BrookI. Spectrum and treatment of anaerobic infections J. Infect. Chemother. 22 1 13 2016 10.1016/j.jiac.2015.10.01026620376 Search in Google Scholar

7 Brook I., Wexler H.M., Goldstein E.J.C.: Antianaerobic Antimicrobials: Spectrum and Susceptibility Testing. Clin. Microbiol. Rev. 26, 526–546 (2013) BrookI. WexlerH.M. GoldsteinE.J.C. Antianaerobic Antimicrobials: Spectrum and Susceptibility Testing Clin. Microbiol. Rev. 26 526 546 2013 10.1128/CMR.00086-12371949623824372 Search in Google Scholar

8 Centers for Disease Control and Prevention (CDC): Multidrug-resistant Bacteroides fragilis-Seattle, Washington, 2013. MMWR. Morb. Mortal. Wkly. Rep. 62, 694–696 (2013) Centers for Disease Control and Prevention (CDC) Multidrug-resistant Bacteroides fragilis-Seattle, Washington, 2013. MMWR Morb. Mortal. Wkly. Rep. 62 694 696 2013 Search in Google Scholar

9 Cobo F., Aliaga L., Expósito-Ruiz M., Navarro-Marí J.M.: Anaerobic bacteraemia: A score predicting mortality. Anaerobe, 64, doi: 10.1016/j.anaerobe.2020.102219 (2020) CoboF. AliagaL. Expósito-RuizM. Navarro-MaríJ.M. Anaerobic bacteraemia: A score predicting mortality Anaerobe 64 10.1016/j.anaerobe.2020.102219 2020 32531433 Open DOISearch in Google Scholar

10 Diniz C.G.: Differential gene expression in a Bacteroides fragilis metronidazole-resistant mutant. J. Antimicrob. Chemother. 54, 100–108 (2004) DinizC.G. Differential gene expression in a Bacteroides fragilis metronidazole-resistant mutant J. Antimicrob. Chemother. 54 100 108 2004 10.1093/jac/dkh25615150173 Search in Google Scholar

11 Dumont Y., Bonzon L., Michon A.L., Carriere C., Didelot M.N., Laurens C., Renard B., Veloo A.C.M., Godreuil S., Jean-Pierre H.: Epidemiology and microbiological features of anaerobic bacteraemia in two French University hospitals. Anaerobe, 64, doi: 10.1016/j.anaerobe.2020.102207 (2020) DumontY. BonzonL. MichonA.L. CarriereC. DidelotM.N. LaurensC. RenardB. VelooA.C.M. GodreuilS. Jean-PierreH. Epidemiology and microbiological features of anaerobic bacteraemia in two French University hospitals Anaerobe 64 10.1016/j.anaerobe.2020.102207 2020 32360436 Open DOISearch in Google Scholar

12 European Committee on Antimicrobial Susceptibility Testing: Clinical breakpoints – breakpoints and guidance v 12.0 January 1, 2022, https://www.eucast.org (01.02.2022) European Committee on Antimicrobial Susceptibility Testing Clinical breakpoints – breakpoints and guidance v 12.0 January 1, 2022 https://www.eucast.org (01.02.2022) Search in Google Scholar

13 Fenner L., Widmer A.F., Straub C., Frei R.: Is the incidence of anaerobic bacteraemia decreasing? Analysis of 114,000 blood cultures over a ten-year period. J. Clin. Microbiol. 46, 2432–2434 (2008) FennerL. WidmerA.F. StraubC. FreiR. Is the incidence of anaerobic bacteraemia decreasing? Analysis of 114,000 blood cultures over a ten-year period J. Clin. Microbiol. 46 2432 2434 2008 10.1128/JCM.00013-08244694218463219 Search in Google Scholar

14 Finegold S.M., George W.L., Mulligan M.E.: Anaerobic infections part II. Dis. Mon. 31, 1–97 (1985) FinegoldS.M. GeorgeW.L. MulliganM.E. Anaerobic infections part II Dis. Mon. 31 1 97 1985 10.1016/0011-5029(85)90027-6 Search in Google Scholar

15 Gajdács M., Urbán E.: Relevance of anaerobic bacteremia in adult patients: A never-ending story? Eur. J. Microbiol. Immunol. 5, 64–75 (2020) GajdácsM. UrbánE. Relevance of anaerobic bacteremia in adult patients: A never-ending story? Eur. J. Microbiol. Immunol. 5 64 75 2020 10.1556/1886.2020.00009739137932590337 Search in Google Scholar

16 Gao Q., Wu S., Xu T., Zhao X., Huang H., Hu F.: Emergence of carbapenem resistance in Bacteroides fragilis in China. Int. J. Antimicrob. Agents. 53, 859–863, (2019) GaoQ. WuS. XuT. ZhaoX. HuangH. HuF. Emergence of carbapenem resistance in Bacteroides fragilis in China Int. J. Antimicrob. Agents. 53 859 863 2019 10.1016/j.ijantimicag.2019.02.01730831235 Search in Google Scholar

17 Genzel G.H., Stubbings W., Stîngu C.S., Labischinski H., Schaumann R.: Activity of the investigational fluoroquinolone finafloxacin and seven other antimicrobial agents against 114 obligately anaerobic bacteria. Int. J. Antimicrob. Agents. 44, 420–423 (2014) GenzelG.H. StubbingsW. StînguC.S. LabischinskiH. SchaumannR. Activity of the investigational fluoroquinolone finafloxacin and seven other antimicrobial agents against 114 obligately anaerobic bacteria Int. J. Antimicrob. Agents. 44 420 423 2014 10.1016/j.ijantimicag.2014.07.00625264128 Search in Google Scholar

18 Grohs P., Mainardi J.L., Podglajen I., Hanras X., Eckert C., Buu-Hoi A., Varon E., Gutmann L.: Relevance of Routine Use of the Anaerobic Blood Culture Bottle. J. Clin. Microbiol. 45, 2711–2715 (2007) GrohsP. MainardiJ.L. PodglajenI. HanrasX. EckertC. Buu-HoiA. VaronE. GutmannL. Relevance of Routine Use of the Anaerobic Blood Culture Bottle J. Clin. Microbiol. 45 2711 2715 2007 10.1128/JCM.00059-07195126317581942 Search in Google Scholar

19 Hartmeyer G.N., Sóki J., Nagy E., Justesen U.S.: Multidrug-resistant Bacteroides fragilis group on the rise in Europe? J. Med. Microbiol. 61, 1784–1788 (2012) HartmeyerG.N. SókiJ. NagyE. JustesenU.S. Multidrug-resistant Bacteroides fragilis group on the rise in Europe? J. Med. Microbiol. 61 1784 1788 2012 10.1099/jmm.0.049825-022956754 Search in Google Scholar

20 Ho P.L., Yau C.Y., Ho L.Y., Lai E.L., Liu M.C., Tse C.W., Chow K.H.: Antimicrobial susceptibility of Bacteroides fragilis group organisms in Hong Kong by the tentative EUCAST disc diffusion method. Anaerobe, 47, 51–56 (2017) HoP.L. YauC.Y. HoL.Y. LaiE.L. LiuM.C. TseC.W. ChowK.H. Antimicrobial susceptibility of Bacteroides fragilis group organisms in Hong Kong by the tentative EUCAST disc diffusion method Anaerobe 47 51 56 2017 10.1016/j.anaerobe.2017.04.00528414107 Search in Google Scholar

21 Kaeuffer C., Ruge T., Diancourt L., Romain B., Ruch Y., Jaulhac B., Boyer P.H. First Case of Bacteraemia Due to Carbapenem-Resistant Bacteroides faecis. Antibiotics (Basel). 19, doi: 10.3390/antibiotics10030319 (2021) KaeufferC. RugeT. DiancourtL. RomainB. RuchY. JaulhacB. BoyerP.H. First Case of Bacteraemia Due to Carbapenem-Resistant Bacteroides faecis Antibiotics (Basel) 19 10.3390/antibiotics10030319 2021 800348133808699 Open DOISearch in Google Scholar

22 Karlowsky J.A., Walkty A.J., Adam H.J., Baxter M.R., Hoban D.J., Zhanel G.G.: Prevalence of Antimicrobial Resistance among Clinical Isolates of Bacteroides fragilis Group in Canada in 2010–2011: CANWARD Surveillance Study. Antimicrob. Agents Chemother. 56, 1247–1252 (2012) KarlowskyJ.A. WalktyA.J. AdamH.J. BaxterM.R. HobanD.J. ZhanelG.G. Prevalence of Antimicrobial Resistance among Clinical Isolates of Bacteroides fragilis Group in Canada in 2010–2011: CANWARD Surveillance Study Antimicrob. Agents Chemother. 56 1247 1252 2012 10.1128/AAC.05823-11329493922203594 Search in Google Scholar

23 Katsandri A., Papaparaskevas J., Pantazatou A., Petrikkos G.L., Thomopoulos G., Houhoula D.P., Avlamis A.: Two Cases of Infections Due to Multidrug-Resistant Bacteroides fragilis Group Strains. J. Clin. Microbiol. 44, 3465–3467 (2006) KatsandriA. PapaparaskevasJ. PantazatouA. PetrikkosG.L. ThomopoulosG. HouhoulaD.P. AvlamisA. Two Cases of Infections Due to Multidrug-Resistant Bacteroides fragilis Group Strains J. Clin. Microbiol. 44 3465 3467 2006 10.1128/JCM.00316-06159466616954304 Search in Google Scholar

24 De Keukeleire S., Wybo I., Naessens A., Echahidi F., Van der Beken M., Vandoorslaer K., Vermeulen S., Piérard D.: Anaerobic bacteraemia: A 10-year retrospective epidemiological survey. Anaerobe, 39, 54–59 (2016) De KeukeleireS. WyboI. NaessensA. EchahidiF. Van der BekenM. VandoorslaerK. VermeulenS. PiérardD. Anaerobic bacteraemia: A 10-year retrospective epidemiological survey Anaerobe 39 54 59 2016 10.1016/j.anaerobe.2016.02.00926923749 Search in Google Scholar

25 Kierzkowska M., Majewska A., Dobrzaniecka K., Sawicka-Grzelak A., Mlynarczyk A., Chmura A., Durlik M., Deborska-Materkowska D., Paczek L., Mlynarczyk G.: Blood Infections in Patients Treated at Transplantation Wards of a Clinical Hospital in Warsaw. Transplant. Proc. 46, 2589–2591 (2014) KierzkowskaM. MajewskaA. DobrzanieckaK. Sawicka-GrzelakA. MlynarczykA. ChmuraA. DurlikM. Deborska-MaterkowskaD. PaczekL. MlynarczykG. Blood Infections in Patients Treated at Transplantation Wards of a Clinical Hospital in Warsaw Transplant. Proc. 46 2589 2591 2014 10.1016/j.transproceed.2014.08.02425380873 Search in Google Scholar

26 Kierzkowska M., Majewska A., Mlynarczyk G. Trends and Impact in Antimicrobial Resistance Among Bacteroides and Parabacteroides Species in 2007–2012 Compared to 2013–2017. Microb. Drug Resist. 26, 1452–1457 (2020) KierzkowskaM. MajewskaA. MlynarczykG. Trends and Impact in Antimicrobial Resistance Among Bacteroides and Parabacteroides Species in 2007–2012 Compared to 2013–2017 Microb. Drug Resist. 26 1452 1457 2020 10.1089/mdr.2019.046232407191 Search in Google Scholar

27 Kierzkowska M., Majewska A., Sawicka-Grzelak A., Młynarczyk G.: Pałeczki gram-ujemne beztlenowo rosnące – diagnostyka i znaczenie kliniczne. Post. Mikrobiol. 55, 91–98 (2016) KierzkowskaM. MajewskaA. Sawicka-GrzelakA. MłynarczykG. Pałeczki gram-ujemne beztlenowo rosnące – diagnostyka i znaczenie kliniczne Post. Mikrobiol. 55 91 98 2016 Search in Google Scholar

28 Kim J., Lee Y., Park Y., Kim M., Choi J.Y., Yong D., Jeong S.H., Lee K.: Anaerobic Bacteraemia: Impact of Inappropriate Therapy on Mortality. Infect. Chemother. 48, 91–98 (2016) KimJ. LeeY. ParkY. KimM. ChoiJ.Y. YongD. JeongS.H. LeeK. Anaerobic Bacteraemia: Impact of Inappropriate Therapy on Mortality Infect. Chemother. 48 91 98 2016 10.3947/ic.2016.48.2.91494573227433379 Search in Google Scholar

29 Lassmamn B., Gustafson D.R., Wood C.M., Rosenblatt J.E.: Reemergence of anaerobic bacteraemia. Clin. Infect. Dis. 44, 895–900 (2007) LassmamnB. GustafsonD.R. WoodC.M. RosenblattJ.E. Reemergence of anaerobic bacteraemia Clin. Infect. Dis. 44 895 900 2007 10.1086/51219717342637 Search in Google Scholar

30 Lee Y., Park Y.J., Kim M.N., Uh Y., Kim M.S., Lee K.: Multicenter study of antimicrobial susceptibility of anaerobic bacteria in Korea in 2012. Ann. Lab. Med. 35, 479–786 (2015) LeeY. ParkY.J. KimM.N. UhY. KimM.S. LeeK. Multicenter study of antimicrobial susceptibility of anaerobic bacteria in Korea in 2012 Ann. Lab. Med. 35 479 786 2015 10.3343/alm.2015.35.5.479451049926206683 Search in Google Scholar

31 Löfmark S., Edlund C., Nord Carl E.: Metronidazole Is Still the Drug of Choice for Treatment of Anaerobic Infections. Clin. Infect. Dis. 50, (2010) LöfmarkS. EdlundC. Nord CarlE. Metronidazole Is Still the Drug of Choice for Treatment of Anaerobic Infections Clin. Infect. Dis. 50 2010 10.1086/64793920067388 Search in Google Scholar

32 Mukhopadhyay S., Puopolo K.M.: Relevance of Neonatal Anaerobic Blood Cultures: New Information for an Old Question. J. Pediatric Infect. Dis. Soc. 17, 126–127 (2018) MukhopadhyayS. PuopoloK.M. Relevance of Neonatal Anaerobic Blood Cultures: New Information for an Old Question J. Pediatric Infect. Dis. Soc. 17 126 127 2018 10.1093/jpids/pix09529165632 Search in Google Scholar

33 Nagy E.: Anaerobic infections: update on treatment considerations. Drugs, 70, 841–858 (2010) NagyE. Anaerobic infections: update on treatment considerations Drugs 70 841 858 2010 10.2165/11534490-000000000-0000020426496 Search in Google Scholar

34 Nagy E., Urbán E.: Antimicrobial susceptibility of Bacteroides fragilis group isolates in Europe: 20 years of experience. Clin. Microbiol. Infect. 17, 371–379 (2011) NagyE. UrbánE. Antimicrobial susceptibility of Bacteroides fragilis group isolates in Europe: 20 years of experience Clin. Microbiol. Infect. 17 371 379 2011 10.1111/j.1469-0691.2010.03256.x20456453 Search in Google Scholar

35 Nagy E., Boyanova L., Justesen U.S.: ESCMID Study Group of Anaerobic Infections. How to isolate, identify and determine antimicrobial susceptibility of anaerobic bacteria in routine laboratories. Clin. Microbiol. Infect. 24, 1139–1148 (2018) NagyE. BoyanovaL. JustesenU.S. ESCMID Study Group of Anaerobic Infections. How to isolate, identify and determine antimicrobial susceptibility of anaerobic bacteria in routine laboratories Clin. Microbiol. Infect. 24 1139 1148 2018 10.1016/j.cmi.2018.02.008 Search in Google Scholar

36 Ngo J.T., Parkins M.D., Gregson D.B., Pitout J.D.D., Ross T., Church D.L., Laupland K.B.: Population-based assessment of the incidence, risk factors, and outcomes of anaerobic bloodstream infections. Infection, 41, 41–48 (2013) NgoJ.T. ParkinsM.D. GregsonD.B. PitoutJ.D.D. RossT. ChurchD.L. LauplandK.B. Population-based assessment of the incidence, risk factors, and outcomes of anaerobic bloodstream infections Infection 41 41 48 2013 10.1007/s15010-012-0389-4 Search in Google Scholar

37 Nguyen M.H., Yu V.L., Morris A.J., McDermott L., Wagener M.W., Harrell L., Snydman D.R.: Antimicrobial Resistance and Clinical Outcome of Bacteroides Bacteraemia: Findings of a Multicenter Prospective Observational Trial. Clin. Infect. Dis. 30, 870–876 (2000) NguyenM.H. YuV.L. MorrisA.J. McDermottL. WagenerM.W. HarrellL. SnydmanD.R. Antimicrobial Resistance and Clinical Outcome of Bacteroides Bacteraemia: Findings of a Multicenter Prospective Observational Trial Clin. Infect. Dis. 30 870 876 2000 10.1086/313805 Search in Google Scholar

38 Ogane K., Maeda T. et al: Antimicrobial susceptibility and prevalence of resistance genes in Bacteroides fragilis isolated from blood culture bottles in two tertiary care hospitals in Japan. Anaerobe, 64, doi: 10.1016/j.anaerobe.2020.102215 (2020) OganeK. MaedaT. Antimicrobial susceptibility and prevalence of resistance genes in Bacteroides fragilis isolated from blood culture bottles in two tertiary care hospitals in Japan Anaerobe 64 10.1016/j.anaerobe.2020.102215 2020 Open DOISearch in Google Scholar

39 Patrick S., Duerden B.I.: Non-Sporing Gram-Negative Anaerobes (in) Principles and Practice of Clinical Bacteriology, Second Edition, Eds. Stephen H. Gillespie S.H., Hawkey P.M., John Wiley & Sons, 2006, 541–556 PatrickS. DuerdenB.I. Non-Sporing Gram-Negative Anaerobes (in) Principles and Practice of Clinical Bacteriology Second Edition Eds. StephenH. GillespieS.H. HawkeyP.M. John Wiley & Sons 2006 541 556 10.1002/9780470017968.ch45 Search in Google Scholar

40 Philippon A., Slama P., Dény P., Labia R.: A Structure-Based Classification of Class A β-Lactamases, a Broadly Diverse Family of Enzymes. Clin. Microbiol. Rev. 29, 29–59 (2016) PhilipponA. SlamaP. DényP. LabiaR. A Structure-Based Classification of Class A β-Lactamases, a Broadly Diverse Family of Enzymes Clin. Microbiol. Rev. 29 29 59 2016 10.1128/CMR.00019-15 Search in Google Scholar

41 Robert R., Deraignac A., Le Moal G., Ragot S., Grollier G. Prognostic factors and impact of antibiotherapy in 117 cases of anaerobic bacteraemia. Eur. J. Clin. Microbiol. Infect. Dis. 27, 671–678 (2008) RobertR. DeraignacA. Le MoalG. RagotS. GrollierG. Prognostic factors and impact of antibiotherapy in 117 cases of anaerobic bacteraemia Eur. J. Clin. Microbiol. Infect. Dis. 27 671 678 2008 10.1007/s10096-008-0487-5 Search in Google Scholar

42 Rodloff A.C., Dowzicky M.J.: In vitro activity of tigecycline and comparators against a European collection of anaerobes collected as part of the Tigecycline Evaluation and Surveillance Trial (T.E.S.T.) 2010–2016. Anaerobe, 51, 78–88 (2018) RodloffA.C. DowzickyM.J. In vitro activity of tigecycline and comparators against a European collection of anaerobes collected as part of the Tigecycline Evaluation and Surveillance Trial (T.E.S.T.) 2010–2016 Anaerobe 51 78 88 2018 10.1016/j.anaerobe.2018.04.009 Search in Google Scholar

43 Rodrigues C., Siciliano R.F., Zeigler R., Strabelli T.M.: Bacteroides fragilis endocarditis: A case report and review of literature. Braz. J. Infect. Dis. 16, 100–104 (2012) RodriguesC. SicilianoR.F. ZeiglerR. StrabelliT.M. Bacteroides fragilis endocarditis: A case report and review of literature Braz. J. Infect. Dis. 16 100 104 2012 10.1016/S1413-8670(12)70285-4 Search in Google Scholar

44 Roh K.H., Kim S., Kim C.K., Yum J.H., Kim M.S., Yong D., Jeong S.H., Lee K., Kim J.M., Chong Y.: New cfiA variant and novel insertion sequence elements in carbapenem-resistant Bacteroides fragilis isolates from Korea. Diagn. Microbiol. Infect. Dis. 66, 343–348 (2010) RohK.H. KimS. KimC.K. YumJ.H. KimM.S. YongD. JeongS.H. LeeK. KimJ.M. ChongY. New cfiA variant and novel insertion sequence elements in carbapenem-resistant Bacteroides fragilis isolates from Korea Diagn. Microbiol. Infect. Dis. 66 343 348 2010 10.1016/j.diagmicrobio.2009.11.00320226324 Search in Google Scholar

45 Rong S.M.M., Rodloff A.C., Stingu C.S.: Diversity of antimicrobial resistance genes in Bacteroides and Parabacteroides strains isolated in Germany. J. Glob. Antimicrob. Resist. 24, 328–334 (2021) RongS.M.M. RodloffA.C. StinguC.S. Diversity of antimicrobial resistance genes in Bacteroides and Parabacteroides strains isolated in Germany J. Glob. Antimicrob. Resist. 24 328 334 2021 10.1016/j.jgar.2021.01.00733508481 Search in Google Scholar

46 Sanford Guide: Antibacterial agents: Spectra of Activity, https://webedition.sanfordguide.com/en (01.02.2022) Sanford Guide Antibacterial agents: Spectra of Activity https://webedition.sanfordguide.com/en (01.02.2022) Search in Google Scholar

47 Schuetz A.N.: Antimicrobial Resistance and Susceptibility Testing of Anaerobic Bacteria. Clin. Infect. Dis. 59, 698–705 (2014) SchuetzA.N. Antimicrobial Resistance and Susceptibility Testing of Anaerobic Bacteria Clin. Infect. Dis. 59 698 705 2014 10.1007/978-3-319-78538-7_6 Search in Google Scholar

48 Shafquat Y., Jabeen K., Farooqi J., Mehmood K., Irfan S., Hasan R., Zafar A.: Antimicrobial susceptibility against metronidazole and carbapenem in clinical anaerobic isolates from Pakistan. Antimicrob. Resist. Infect. Control. 14, doi: 10.1186/s13756-019-0549-8 (2019) ShafquatY. JabeenK. FarooqiJ. MehmoodK. IrfanS. HasanR. ZafarA. Antimicrobial susceptibility against metronidazole and carbapenem in clinical anaerobic isolates from Pakistan Antimicrob. Resist. Infect. Control. 14 10.1186/s13756-019-0549-8 2019 656747931210928 Open DOISearch in Google Scholar

49 Sherwood J.E., Fraser S., Citron D.M., Wexler H., Blakely G., Jobling K., Patrick S.: Multi-drug resistant Bacteroides fragilis recovered from blood and severe leg wounds caused by an improvised explosive device (IED) in Afghanistan. Anaerobe, 17, 152–155 (2011) SherwoodJ.E. FraserS. CitronD.M. WexlerH. BlakelyG. JoblingK. PatrickS. Multi-drug resistant Bacteroides fragilis recovered from blood and severe leg wounds caused by an improvised explosive device (IED) in Afghanistan Anaerobe 17 152 155 2011 10.1016/j.anaerobe.2011.02.00721376821 Search in Google Scholar

50 Shimura S., Wada Y. et al: Antimicrobial susceptibility surveillance of obligate anaerobic bacteria in the Kinki area. J. Infect. Chemother. 25, 837–844 (2019) ShimuraS. WadaY. Antimicrobial susceptibility surveillance of obligate anaerobic bacteria in the Kinki area J. Infect. Chemother. 25 837 844 2019 10.1016/j.jiac.2019.07.01831427200 Search in Google Scholar

51 Snydman D.R., Jacobus N.V., McDermott L.A., Goldstein E.J.C., Harrell L., Jenkins S.G., Newton D., Patel R., Hecht D.W.: Trends in antimicrobial resistance among Bacteroides species and Parabacteroides species in the United States from 2010–2012 with comparison to 2008–2009. Anaerobe, 43, 21–26 (2017) SnydmanD.R. JacobusN.V. McDermottL.A. GoldsteinE.J.C. HarrellL. JenkinsS.G. NewtonD. PatelR. HechtD.W. Trends in antimicrobial resistance among Bacteroides species and Parabacteroides species in the United States from 2010–2012 with comparison to 2008–2009 Anaerobe 43 21 26 2017 10.1016/j.anaerobe.2016.11.00327867083 Search in Google Scholar

52 Sóki J.: Extended role for insertion sequence elements in the antibiotic resistance of Bacteroides. World J. Clin. Infect. Dis. 3, 1–12 (2013) SókiJ. Extended role for insertion sequence elements in the antibiotic resistance of Bacteroides World J. Clin. Infect. Dis. 3 1 12 2013 10.5495/wjcid.v3.i1 Search in Google Scholar

53 Sóki J., Gonzalez S.M., Urban E., Nagy E., Ayala J.A.: Molecular analysis of the effector mechanisms of cefoxitin resistance among Bacteroides strains. J. Antimicrob. Chemother. 66, 2492–500 (2011) SókiJ. GonzalezS.M. UrbanE. NagyE. AyalaJ.A. Molecular analysis of the effector mechanisms of cefoxitin resistance among Bacteroides strains J. Antimicrob. Chemother. 66 2492 500 2011 10.1093/jac/dkr33921873290 Search in Google Scholar

54 Song Y.L., Liu C.X., McTeague M., Finegold S.M.: “Bacteroides nordii” sp. nov. and “Bacteroides salyersae” sp. nov. Isolated from Clinical Specimens of Human Intestinal Origin. J. Clin. Microbiol. 42, 5565–5570 (2004) SongY.L. LiuC.X. McTeagueM. FinegoldS.M. “Bacteroides nordii” sp. nov. and “Bacteroides salyersae” sp. nov. Isolated from Clinical Specimens of Human Intestinal Origin J. Clin. Microbiol. 42 5565 5570 2004 10.1128/JCM.42.12.5565-5570.200453527415583282 Search in Google Scholar

55 Snydman D.R., Gorbach S.L. et al: Lessons learned from the anaerobe survey: historical perspective and review of the most recent data (2005–2007). Clin. Infect. Dis. 50, 26–33 (2010) SnydmanD.R. GorbachS.L. Lessons learned from the anaerobe survey: historical perspective and review of the most recent data (2005–2007) Clin. Infect. Dis. 50 26 33 2010 10.1086/64794020067390 Search in Google Scholar

56 Snydman D.R., Hecht D.W. et al: Update on resistance of Bacteroides fragilis group and related species with special attention to carbapenems 2006–2009. Anaerobe, 17, 147–151 (2011) SnydmanD.R. HechtD.W. Update on resistance of Bacteroides fragilis group and related species with special attention to carbapenems 2006–2009 Anaerobe 17 147 151 2011 10.1016/j.anaerobe.2011.05.014 Search in Google Scholar

57 Tan T.Y., Ng L.S.Y., Kwang L.L., Rao S., Eng L.C.: Clinical characteristics and antimicrobial susceptibilities of anaerobic bacteraemia in an acute care hospital. Anaerobe, 43, 69–74 (2017) TanT.Y. NgL.S.Y. KwangL.L. RaoS. EngL.C. Clinical characteristics and antimicrobial susceptibilities of anaerobic bacteraemia in an acute care hospital Anaerobe 43 69 74 2017 10.1016/j.anaerobe.2016.11.009 Search in Google Scholar

58 Toprak N.U., Uzunkaya O.D., Sóki J., Soyletir G.: Susceptibility profiles and resistance genes for carbapenems (cfiA) and metronidazole (nim) among Bacteroides species in a Turkish University Hospital. Anaerobe, 18, 169–171 (2012) ToprakN.U. UzunkayaO.D. SókiJ. SoyletirG. Susceptibility profiles and resistance genes for carbapenems (cfiA) and metronidazole (nim) among Bacteroides species in a Turkish University Hospital Anaerobe 18 169 171 2012 10.1016/j.anaerobe.2011.10.004 Search in Google Scholar

59 Turner P., Edwards R., Weston V., Ispahani P., Greenwood D., Gazis A.: Simultaneous resistance to metronidazole, co-amoxiclav, and imipenem in clinical isolate of Bacteroides fragilis. The Lancet, 345, 1275–1277 (1995) TurnerP. EdwardsR. WestonV. IspahaniP. GreenwoodD. GazisA. Simultaneous resistance to metronidazole, co-amoxiclav, and imipenem in clinical isolate of Bacteroides fragilis The Lancet 345 1275 1277 1995 10.1016/S0140-6736(95)90927-3 Search in Google Scholar

60 Umemura T., Hamada Y., Yamagishi Y., Suematsu H., Mikamo H.: Clinical characteristics associated with mortality of patients with anaerobic bacteraemia. Anaerobe, 39, 45–50 (2016) UmemuraT. HamadaY. YamagishiY. SuematsuH. MikamoH. Clinical characteristics associated with mortality of patients with anaerobic bacteraemia Anaerobe 39 45 50 2016 10.1016/j.anaerobe.2016.02.00726903282 Search in Google Scholar

61 Urbán E.: Five-year retrospective epidemiological survey of anaerobic bacteraemia in a University Hospital and Review of the Literature. Eur. J. Microbiol. Immunol. (Bp). 2, 140–147 (2012) UrbánE. Five-year retrospective epidemiological survey of anaerobic bacteraemia in a University Hospital and Review of the Literature Eur. J. Microbiol. Immunol. (Bp). 2 140 147 2012 10.1556/EuJMI.2.2012.2.7395696324672683 Search in Google Scholar

62 Vena A., Muñoz P., Alcalá L., Fernandez-Cruz A., Sanchez C., Valerio M., Bouza E.: Are incidence and epidemiology of anaerobic bacteraemia really changing? Eur. J. Clin. Microbiol. Infect. Dis. 34, 1621–1629 (2015) VenaA. MuñozP. AlcaláL. Fernandez-CruzA. SanchezC. ValerioM. BouzaE. Are incidence and epidemiology of anaerobic bacteraemia really changing? Eur. J. Clin. Microbiol. Infect. Dis. 34 1621 1629 2015 10.1007/s10096-015-2397-726017663 Search in Google Scholar

63 Wang F.D., Liao C.H., Lin Y.T., Sheng W.H., Hsueh P.R.: Trends in the susceptibility of commonly encountered clinically significant anaerobes and susceptibilities of blood isolates of anaerobes to 16 antimicrobial agents, including fidaxomicin and rifaximin, 2008–2012, northern Taiwan. Eur. J. Clin. Microbiol. Infect. Dis. 33, 2041–2052 (2014) WangF.D. LiaoC.H. LinY.T. ShengW.H. HsuehP.R. Trends in the susceptibility of commonly encountered clinically significant anaerobes and susceptibilities of blood isolates of anaerobes to 16 antimicrobial agents, including fidaxomicin and rifaximin, 2008–2012, northern Taiwan Eur. J. Clin. Microbiol. Infect. Dis. 33 2041 2052 2014 10.1007/s10096-014-2175-y24930042 Search in Google Scholar

64 Wareham D.W., Wilks M., Ahmed D., Brazier J.S., Millar M.: Anaerobic Sepsis Due to Multidrug-Resistant Bacteroides fragilis: Microbiological Cure and Clinical Response with Linezolid Therapy. Clin. Infect. Dis. 40, 67–68 (2005) WarehamD.W. WilksM. AhmedD. BrazierJ.S. MillarM. Anaerobic Sepsis Due to Multidrug-Resistant Bacteroides fragilis: Microbiological Cure and Clinical Response with Linezolid Therapy Clin. Infect. Dis. 40 67 68 2005 10.1086/428623 Search in Google Scholar

65 Wexler H.M.: Bacteroides: the Good, the Bad, and the Nitty-Gritty. Clin. Microbiol. Rev. 20, 593–621 (2007) WexlerH.M. Bacteroides: the Good, the Bad, and the Nitty-Gritty Clin. Microbiol. Rev. 20 593 621 2007 10.1128/CMR.00008-07217604517934076 Search in Google Scholar

66 Wexler H.M.: The Genus Bacteroides (in) The Prokaryotes, eds. Rosenberg E., DeLong E.F., Lory S., Stackebrandt E., Thompson F., Springer, Berlin, 2014, 459–484 WexlerH.M. The Genus Bacteroides (in) The Prokaryotes eds. RosenbergE. DeLongE.F. LoryS. StackebrandtE. ThompsonF. Springer Berlin 2014 459 484 10.1007/978-3-642-38954-2_129 Search in Google Scholar

67 Yarbrough M.L., Wallace M.A., Burnham C.D.: Comparision of microorganism detection and time to positivity in pediatric and standard media from three major commercial continuously monitored blood culture systems. J. Clin. Microbiol. 59, e00429–21 (2021) YarbroughM.L. WallaceM.A. BurnhamC.D. Comparision of microorganism detection and time to positivity in pediatric and standard media from three major commercial continuously monitored blood culture systems J. Clin. Microbiol. 59 e00429 21 2021 10.1128/JCM.00429-21 Search in Google Scholar

68 Yoshino Y., Kitazawa T., Ikeda M., Tatsuno K., Yanagimoto S., Okugawa S., Ota Y., Yotsuyanagi H.: Clinical features of Bacteroides bacteraemia and their association with colorectal carcinoma. Infection, 40, 63–67 (2012) YoshinoY. KitazawaT. IkedaM. TatsunoK. YanagimotoS. OkugawaS. OtaY. YotsuyanagiH. Clinical features of Bacteroides bacteraemia and their association with colorectal carcinoma Infection 40 63 67 2012 10.1007/s15010-011-0159-821773761 Search in Google Scholar

69 Zafar H., Saier M.H. Jr. Gut Bacteroides species in health and disease. Gut Microbes, 13, 1–20 (2021) ZafarH. SaierM.H.Jr. Gut Bacteroides species in health and disease Gut Microbes 13 1 20 2021 10.1080/19490976.2020.1848158787203033535896 Search in Google Scholar

70 Zahar J.R., Farhat H., Chachaty E., Meshaka P., Antoun S., Nitenberg G. Incidence and clinical significance of anaerobic bacteraemia in cancer patients: a 6-year retrospective study. Clin. Microbiol. Infect. 11, 724–729 (2005) ZaharJ.R. FarhatH. ChachatyE. MeshakaP. AntounS. NitenbergG. Incidence and clinical significance of anaerobic bacteraemia in cancer patients: a 6-year retrospective study Clin. Microbiol. Infect. 11 724 729 2005 10.1111/j.1469-0691.2005.01214.x16104987 Search in Google Scholar